37,95 €
37,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
19 °P sammeln
37,95 €
37,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
19 °P sammeln
Als Download kaufen
37,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
19 °P sammeln
Jetzt verschenken
37,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
19 °P sammeln
  • Format: ePub

Market driven healthcare is massively divisive. Opponents argue that a competition approach to medical treatment negatively impacts on quality, while advocates point to increased efficiencies. This book casts a critical eye over both positions to show that the concerns over quality are in fact real. Taking a two part approach, it unveils the fault lines along which healthcare provision and the pursuit of quality would in certain cases clash. It then shows how competition authorities can only effectively assess competition concerns when they ask the fundamental question of how the concept of…mehr

  • Geräte: eReader
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 0.45MB
Produktbeschreibung
Market driven healthcare is massively divisive. Opponents argue that a competition approach to medical treatment negatively impacts on quality, while advocates point to increased efficiencies. This book casts a critical eye over both positions to show that the concerns over quality are in fact real. Taking a two part approach, it unveils the fault lines along which healthcare provision and the pursuit of quality would in certain cases clash. It then shows how competition authorities can only effectively assess competition concerns when they ask the fundamental question of how the concept of healthcare quality should be defined and factored into their decisions. Drawing on UK, US and EU examples, it explores antitrust and merger cases in hospital, medical and health insurance markets to give an accurate depiction of the reality and challenges of regulating competition in healthcare provision.
Autorenporträt
Theodosia Stavroulaki is Assistant Professor of Law at Gonzaga University School of Law, USA. Her teaching and research interests include antitrust, health law, and law and inequality. Before joining Gonzaga University Theodosia served as a Jaharis Faculty Fellow at the DePaul College of Law, Grotius Research Scholar at Michigan University School of Law, and Hauser Global Fellow at NYU School of Law. She also served as a visiting researcher at Georgetown Law School and at the London School of Economics. Her scholarship has been published in the Journal of Competition Law & Economics, Berkeley Business Law Journal, World Competition, Loyola Consumer Law Review and the American Journal of Law & Medicine. Theodosia's article, 'Mergers that Harm Our Health', (2022)19 Berkeley Bus LJ, was nominated for the Best Academic Article (mergers category) in the 2021 Concurrences Antitrust Writing Awards organized by George Washington University and the journal Concurrences. Theodosia's forthcoming book, Healthcare, Quality Concerns and Competition Law: A Systematic Approach (Hart Publishing) explores how health care quality concerns are considered by competition authorities on both sides of the Atlantic. Theodosia's research has been funded by a number of prestigious institutions including the American Bar Association Section of Antitrust Law, the Fulbright Commission, NYU School of Law, Michigan Law School, European University Institute, Tel Aviv University, the European Commission, the Greek Scholarships Foundation and the Greek Association of Law and Economics. Before commencing her academic career, Theodosia worked as an antitrust associate in a leading law firm in Greece, where she advised multinational firms in a broad range of antitrust and business issues, and a lawyer at the Policy Unit of DG Competition of the European Commission. Theodosia holds a PhD in antitrust law from the European University Institute.